Compugen Ltd. (NASDAQ: CGEN) announced that a pooled analysis of its COM701 cancer treatment will be presented at the European ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE